Skip to search formSkip to main contentSkip to account menu

CK 2289

Known as: CK-2289 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
We examined the hemodynamic profile of CK‐2289, a new imidazolone developed for the treatment of congestive heart failure, in the… 
1991
1991
We examined the interaction between ouabain and CK‐2289, a new bivalent inodilator, and compared their effect with that of… 
1991
1991
CK-2289 is an inhibitor of type III cyclic 3'5'-adenosine monophosphate phosphodiesterase with potential utility in the treatment…